114 related articles for article (PubMed ID: 27238949)
1. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
Arredondo A; Duarte MB; Cuadra SM
Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
Arredondo A; Zúñiga A; Parada I
Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico.
Arredondo A; Zuñiga A
Cad Saude Publica; 2012 Mar; 28(3):497-502. PubMed ID: 22415182
[TBL] [Abstract][Full Text] [Related]
4. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
Arredondo A; Cuadra SM; Duarte MB
BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.
Arredondo A; Zúñiga A
Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225
[TBL] [Abstract][Full Text] [Related]
6. Recent trends for the management of hypertension in older adults in Latin America in the context of universal coverage: Evidence from Mexico.
Arredondo A; Recamán AL; Suarez-Herrera JC; Cuadra SM
Int J Health Plann Manage; 2021 Mar; 36(2):579-586. PubMed ID: 33368667
[TBL] [Abstract][Full Text] [Related]
7. [The cost of diabetes in Latin America: evidence from Mexico].
Arredondo A; De Icaza E
Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
[TBL] [Abstract][Full Text] [Related]
8. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
[TBL] [Abstract][Full Text] [Related]
9. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
Arredondo A; Aviles R
PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
[TBL] [Abstract][Full Text] [Related]
10. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
Arredondo A; Zúñiga A
Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
[TBL] [Abstract][Full Text] [Related]
11. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
Arredondo A
Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
[TBL] [Abstract][Full Text] [Related]
12. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
Arredondo A; Reyes G
PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
[TBL] [Abstract][Full Text] [Related]
13. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
Arredondo A; Azar A; Recamán AL
Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
[TBL] [Abstract][Full Text] [Related]
14. "Epidemiological changes and economic burden of hypertension in Latin America: evidence from Mexico".
Barceló A
Am J Hypertens; 2006 Jun; 19(6):551-2. PubMed ID: 16733224
[No Abstract] [Full Text] [Related]
15. Costs and financial consequences of the changing epidemiological profile in Mexico.
Arredondo A
Health Policy; 1997 Oct; 42(1):39-48. PubMed ID: 10173492
[TBL] [Abstract][Full Text] [Related]
16. Recent trends for the management of diabetes for older adults in the context of universal coverage and COVID-19: evidence from Mexico.
Arredondo A
Int Health; 2021 Sep; 13(5):488-491. PubMed ID: 33210109
[TBL] [Abstract][Full Text] [Related]
17. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.
Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A
Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico.
Arredondo A; Carrillo C; Zuñiga A
Rev Saude Publica; 2007 Aug; 41(4):523-9. PubMed ID: 17589749
[TBL] [Abstract][Full Text] [Related]
19. [The challenges of the family planning program].
Alarcon F; Mojarro O
Demos; 1991; (4):11-2. PubMed ID: 12158037
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological transition in Latin America: a comparison of four countries].
Albala C; Vio F; Yáñez M
Rev Med Chil; 1997 Jun; 125(6):719-27. PubMed ID: 9580335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
